Statistics for Reneo Pharmaceuticals, (id:6676 RPHM)
Valuation metrics
Market cap
60.84M
Enterprise value
-15,010,566.00
Trailing P/E (ttm)
-6.17
Forward P/E
-47.89
PEG ratio
-47.89
Price/Sales (ttm)
Price/Book (mrq)
0.79
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.25
Overview
Shares outstanding
3.34M
Float
3.33M
Shares short
339.83K
% Held by insiders
% Held by institutions
Average volume (10 days)
41.61K
Average volume (90 days)
Price summary
52-Week low
9.80
52-Week high
77.60
52-Week change
-279.42%
Beta
0.22
50-Day moving average
14.92
200-Day moving average
16.09
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 07th, 2024
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-33.72%
Return on equity
-54.00%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-61,057,000.00
Net income to common (ttm)
-56,537,000.00
Diluted EPS (ttm)
-16.80
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
76.67M
Total cash per share (mrq)
22.94
Total debt (mrq)
823.00K
Total Debt/Equity (mrq)
1.07
Current ratio (mrq)
5.79K%
Book value per share (mrq)
23.00
Cash flow
Cash flow statement
-66,341,000.00
Levered free cash flow (LFCF)
-43,424,500.00